nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Etoposide—germ cell cancer	0.408	1	CiPCiCtD
Irinotecan—pancreatic cancer—germ cell cancer	0.21	1	CtDrD
Irinotecan—SLC22A3—germ cell cancer	0.162	1	CbGaD
Irinotecan—ABCC1—Dactinomycin—germ cell cancer	0.0144	0.0886	CbGbCtD
Irinotecan—UGT1A1—Etoposide—germ cell cancer	0.00985	0.0608	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—germ cell cancer	0.00961	0.0593	CbGbCtD
Irinotecan—ABCC1—Vinblastine—germ cell cancer	0.00899	0.0555	CbGbCtD
Irinotecan—CYP3A7—Ifosfamide—germ cell cancer	0.00838	0.0517	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.00838	0.0517	CbGbCtD
Irinotecan—ABCC1—Etoposide—germ cell cancer	0.0081	0.05	CbGbCtD
Irinotecan—CYP2B6—Ifosfamide—germ cell cancer	0.00798	0.0492	CbGbCtD
Irinotecan—BCHE—Cisplatin—germ cell cancer	0.00784	0.0484	CbGbCtD
Irinotecan—ABCC2—Vinblastine—germ cell cancer	0.00666	0.0411	CbGbCtD
Irinotecan—CYP3A5—Ifosfamide—germ cell cancer	0.00628	0.0388	CbGbCtD
Irinotecan—ABCC2—Cisplatin—germ cell cancer	0.0061	0.0377	CbGbCtD
Irinotecan—ABCC2—Etoposide—germ cell cancer	0.006	0.037	CbGbCtD
Irinotecan—ABCG2—Cisplatin—germ cell cancer	0.00552	0.034	CbGbCtD
Irinotecan—ABCG2—Etoposide—germ cell cancer	0.00542	0.0335	CbGbCtD
Irinotecan—ABCC1—Methotrexate—germ cell cancer	0.00535	0.033	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—germ cell cancer	0.00451	0.0278	CbGbCtD
Irinotecan—ABCC2—Methotrexate—germ cell cancer	0.00396	0.0244	CbGbCtD
Irinotecan—CYP2B6—Cisplatin—germ cell cancer	0.00388	0.0239	CbGbCtD
Irinotecan—ABCG2—Methotrexate—germ cell cancer	0.00358	0.0221	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—germ cell cancer	0.00346	0.0214	CbGbCtD
Irinotecan—CYP3A5—Etoposide—germ cell cancer	0.003	0.0185	CbGbCtD
Irinotecan—ALB—Methotrexate—germ cell cancer	0.00247	0.0152	CbGbCtD
Irinotecan—CYP3A4—Ifosfamide—germ cell cancer	0.00245	0.0151	CbGbCtD
Irinotecan—ABCB1—Vinblastine—germ cell cancer	0.00217	0.0134	CbGbCtD
Irinotecan—ABCB1—Cisplatin—germ cell cancer	0.00199	0.0123	CbGbCtD
Irinotecan—ABCB1—Etoposide—germ cell cancer	0.00195	0.0121	CbGbCtD
Irinotecan—CYP3A4—Vinblastine—germ cell cancer	0.0013	0.00802	CbGbCtD
Irinotecan—ABCB1—Methotrexate—germ cell cancer	0.00129	0.00797	CbGbCtD
Irinotecan—CYP3A4—Etoposide—germ cell cancer	0.00117	0.00723	CbGbCtD
Irinotecan—UGT1A1—urine—germ cell cancer	0.000604	0.0383	CbGeAlD
Irinotecan—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00039	0.101	CbGpPWpGaD
Irinotecan—TOP1MT—gonad—germ cell cancer	0.000326	0.0207	CbGeAlD
Irinotecan—TOP1MT—adrenal gland—germ cell cancer	0.000284	0.018	CbGeAlD
Irinotecan—TOP1MT—female gonad—germ cell cancer	0.000265	0.0168	CbGeAlD
Irinotecan—TOP1—trigeminal ganglion—germ cell cancer	0.000262	0.0166	CbGeAlD
Irinotecan—TOP1MT—endocrine gland—germ cell cancer	0.000246	0.0156	CbGeAlD
Irinotecan—TOP1MT—head—germ cell cancer	0.000243	0.0154	CbGeAlD
Irinotecan—CES2—trigeminal ganglion—germ cell cancer	0.000238	0.0151	CbGeAlD
Irinotecan—TOP1MT—testis—germ cell cancer	0.000235	0.0149	CbGeAlD
Irinotecan—CES1—neck—germ cell cancer	0.000227	0.0144	CbGeAlD
Irinotecan—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000224	0.058	CbGpPWpGaD
Irinotecan—TOP1—retina—germ cell cancer	0.000224	0.0142	CbGeAlD
Irinotecan—TOP1MT—cerebellum—germ cell cancer	0.000217	0.0137	CbGeAlD
Irinotecan—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000211	0.0546	CbGpPWpGaD
Irinotecan—TOP1—telencephalon—germ cell cancer	0.000206	0.0131	CbGeAlD
Irinotecan—ACHE—Synthesis, secretion, and deacylation of Ghrelin—KLF4—germ cell cancer	0.000205	0.0532	CbGpPWpGaD
Irinotecan—CES2—eye—germ cell cancer	0.000205	0.013	CbGeAlD
Irinotecan—CES2—retina—germ cell cancer	0.000203	0.0129	CbGeAlD
Irinotecan—ACHE—trigeminal ganglion—germ cell cancer	0.000196	0.0124	CbGeAlD
Irinotecan—TOP1—decidua—germ cell cancer	0.000195	0.0124	CbGeAlD
Irinotecan—CYP3A4—urine—germ cell cancer	0.000194	0.0123	CbGeAlD
Irinotecan—CES2—telencephalon—germ cell cancer	0.000187	0.0118	CbGeAlD
Irinotecan—BCHE—Synthesis, secretion, and deacylation of Ghrelin—KLF4—germ cell cancer	0.000183	0.0474	CbGpPWpGaD
Irinotecan—CES2—skin of body—germ cell cancer	0.000178	0.0113	CbGeAlD
Irinotecan—CES2—decidua—germ cell cancer	0.000177	0.0112	CbGeAlD
Irinotecan—TOP1MT—brain—germ cell cancer	0.000176	0.0112	CbGeAlD
Irinotecan—TOP1—uterus—germ cell cancer	0.000171	0.0108	CbGeAlD
Irinotecan—TOP1MT—lymph node—germ cell cancer	0.00017	0.0108	CbGeAlD
Irinotecan—TOP1—pituitary gland—germ cell cancer	0.000168	0.0106	CbGeAlD
Irinotecan—TOP1—medulla oblongata—germ cell cancer	0.000162	0.0103	CbGeAlD
Irinotecan—CES2—gonad—germ cell cancer	0.000156	0.00988	CbGeAlD
Irinotecan—CES2—uterus—germ cell cancer	0.000155	0.00982	CbGeAlD
Irinotecan—ACHE—telencephalon—germ cell cancer	0.000154	0.00975	CbGeAlD
Irinotecan—CES2—pituitary gland—germ cell cancer	0.000152	0.00964	CbGeAlD
Irinotecan—TOP1—adrenal gland—germ cell cancer	0.00015	0.0095	CbGeAlD
Irinotecan—TOP1—midbrain—germ cell cancer	0.000148	0.00937	CbGeAlD
Irinotecan—CES2—medulla oblongata—germ cell cancer	0.000147	0.0093	CbGeAlD
Irinotecan—UGT1A9—endocrine gland—germ cell cancer	0.000146	0.00926	CbGeAlD
Irinotecan—TOP1—bone marrow—germ cell cancer	0.000145	0.00919	CbGeAlD
Irinotecan—TOP1—spinal cord—germ cell cancer	0.000144	0.00915	CbGeAlD
Irinotecan—TOP1—female gonad—germ cell cancer	0.00014	0.00885	CbGeAlD
Irinotecan—SLC22A3—trigeminal ganglion—germ cell cancer	0.000136	0.00862	CbGeAlD
Irinotecan—CES2—adrenal gland—germ cell cancer	0.000136	0.00861	CbGeAlD
Irinotecan—CES2—midbrain—germ cell cancer	0.000134	0.0085	CbGeAlD
Irinotecan—CES2—bone marrow—germ cell cancer	0.000131	0.00833	CbGeAlD
Irinotecan—SLC22A3—embryo—germ cell cancer	0.000131	0.00832	CbGeAlD
Irinotecan—CES2—spinal cord—germ cell cancer	0.000131	0.0083	CbGeAlD
Irinotecan—CES2—female gonad—germ cell cancer	0.000127	0.00803	CbGeAlD
Irinotecan—TOP1—testis—germ cell cancer	0.000124	0.00785	CbGeAlD
Irinotecan—CYP3A7—endocrine gland—germ cell cancer	0.000122	0.0077	CbGeAlD
Irinotecan—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000121	0.0314	CbGpPWpGaD
Irinotecan—ACHE—medulla oblongata—germ cell cancer	0.000121	0.00766	CbGeAlD
Irinotecan—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000121	0.0312	CbGpPWpGaD
Irinotecan—CES2—endocrine gland—germ cell cancer	0.000118	0.00747	CbGeAlD
Irinotecan—CES2—head—germ cell cancer	0.000116	0.00737	CbGeAlD
Irinotecan—TOP1—cerebellum—germ cell cancer	0.000114	0.00725	CbGeAlD
Irinotecan—CES2—NRF2 pathway—SLC2A3—germ cell cancer	0.000114	0.0296	CbGpPWpGaD
Irinotecan—CES2—testis—germ cell cancer	0.000112	0.00712	CbGeAlD
Irinotecan—ACHE—adrenal gland—germ cell cancer	0.000112	0.00709	CbGeAlD
Irinotecan—CES1—adrenal gland—germ cell cancer	0.000112	0.00709	CbGeAlD
Irinotecan—ACHE—midbrain—germ cell cancer	0.00011	0.007	CbGeAlD
Irinotecan—ACHE—spinal cord—germ cell cancer	0.000108	0.00683	CbGeAlD
Irinotecan—SLCO1B1—Transport of organic anions—AVP—germ cell cancer	0.000105	0.0272	CbGpPWpGaD
Irinotecan—CES1—female gonad—germ cell cancer	0.000104	0.00661	CbGeAlD
Irinotecan—CES2—cerebellum—germ cell cancer	0.000104	0.00658	CbGeAlD
Irinotecan—ACHE—Monoamine Transport—PVRL2—germ cell cancer	0.000101	0.0262	CbGpPWpGaD
Irinotecan—UGT1A1—endocrine gland—germ cell cancer	0.0001	0.00635	CbGeAlD
Irinotecan—UGT1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.0001	0.0259	CbGpPWpGaD
Irinotecan—UGT1A9—Metapathway biotransformation—NAT9—germ cell cancer	0.0001	0.0259	CbGpPWpGaD
Irinotecan—CES1—endocrine gland—germ cell cancer	9.7e-05	0.00615	CbGeAlD
Irinotecan—BCHE—trigeminal ganglion—germ cell cancer	9.63e-05	0.0061	CbGeAlD
Irinotecan—CES1—head—germ cell cancer	9.58e-05	0.00607	CbGeAlD
Irinotecan—ABCG2—trigeminal ganglion—germ cell cancer	9.3e-05	0.0059	CbGeAlD
Irinotecan—TOP1—brain—germ cell cancer	9.29e-05	0.00589	CbGeAlD
Irinotecan—ACHE—testis—germ cell cancer	9.25e-05	0.00586	CbGeAlD
Irinotecan—CES1—testis—germ cell cancer	9.25e-05	0.00586	CbGeAlD
Irinotecan—TOP1—lymph node—germ cell cancer	8.98e-05	0.00569	CbGeAlD
Irinotecan—SLC22A3—gonad—germ cell cancer	8.91e-05	0.00565	CbGeAlD
Irinotecan—ABCC1—telencephalon—germ cell cancer	8.83e-05	0.00559	CbGeAlD
Irinotecan—ACHE—cerebellum—germ cell cancer	8.55e-05	0.00542	CbGeAlD
Irinotecan—BCHE—brainstem—germ cell cancer	8.52e-05	0.0054	CbGeAlD
Irinotecan—CES2—brain—germ cell cancer	8.43e-05	0.00534	CbGeAlD
Irinotecan—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	8.41e-05	0.0218	CbGpPWpGaD
Irinotecan—ABCC1—decidua—germ cell cancer	8.36e-05	0.0053	CbGeAlD
Irinotecan—SLCO1B1—endocrine gland—germ cell cancer	8.34e-05	0.00528	CbGeAlD
Irinotecan—CES2—lymph node—germ cell cancer	8.14e-05	0.00516	CbGeAlD
Irinotecan—ALB—adrenal gland—germ cell cancer	7.78e-05	0.00493	CbGeAlD
Irinotecan—SLC22A3—adrenal gland—germ cell cancer	7.76e-05	0.00492	CbGeAlD
Irinotecan—BCHE—telencephalon—germ cell cancer	7.56e-05	0.00479	CbGeAlD
Irinotecan—ABCB1—blood vessel—germ cell cancer	7.43e-05	0.00471	CbGeAlD
Irinotecan—ABCC1—uterus—germ cell cancer	7.32e-05	0.00464	CbGeAlD
Irinotecan—ABCG2—telencephalon—germ cell cancer	7.31e-05	0.00463	CbGeAlD
Irinotecan—ABCC2—adrenal gland—germ cell cancer	7.29e-05	0.00462	CbGeAlD
Irinotecan—SLC22A3—female gonad—germ cell cancer	7.24e-05	0.00459	CbGeAlD
Irinotecan—BCHE—skin of body—germ cell cancer	7.21e-05	0.00457	CbGeAlD
Irinotecan—ABCC1—pituitary gland—germ cell cancer	7.19e-05	0.00455	CbGeAlD
Irinotecan—CES1—brain—germ cell cancer	6.94e-05	0.0044	CbGeAlD
Irinotecan—ACHE—brain—germ cell cancer	6.94e-05	0.0044	CbGeAlD
Irinotecan—ABCG2—decidua—germ cell cancer	6.92e-05	0.00439	CbGeAlD
Irinotecan—SLC22A3—endocrine gland—germ cell cancer	6.73e-05	0.00427	CbGeAlD
Irinotecan—CES1—NRF2 pathway—SLC2A3—germ cell cancer	6.73e-05	0.0174	CbGpPWpGaD
Irinotecan—Chills—Ifosfamide—germ cell cancer	6.72e-05	0.00177	CcSEcCtD
Irinotecan—ACHE—lymph node—germ cell cancer	6.71e-05	0.00425	CbGeAlD
Irinotecan—CES1—lymph node—germ cell cancer	6.71e-05	0.00425	CbGeAlD
Irinotecan—Arrhythmia—Ifosfamide—germ cell cancer	6.69e-05	0.00177	CcSEcCtD
Irinotecan—Cough—Bleomycin—germ cell cancer	6.65e-05	0.00176	CcSEcCtD
Irinotecan—SLC22A3—head—germ cell cancer	6.65e-05	0.00421	CbGeAlD
Irinotecan—Pneumonia—Etoposide—germ cell cancer	6.62e-05	0.00175	CcSEcCtD
Irinotecan—Paraesthesia—Vinblastine—germ cell cancer	6.61e-05	0.00175	CcSEcCtD
Irinotecan—Alopecia—Ifosfamide—germ cell cancer	6.61e-05	0.00175	CcSEcCtD
Irinotecan—Ill-defined disorder—Dactinomycin—germ cell cancer	6.6e-05	0.00174	CcSEcCtD
Irinotecan—Anaemia—Dactinomycin—germ cell cancer	6.57e-05	0.00174	CcSEcCtD
Irinotecan—Bradycardia—Cisplatin—germ cell cancer	6.57e-05	0.00174	CcSEcCtD
Irinotecan—Acute coronary syndrome—Etoposide—germ cell cancer	6.49e-05	0.00172	CcSEcCtD
Irinotecan—Renal failure—Etoposide—germ cell cancer	6.47e-05	0.00171	CcSEcCtD
Irinotecan—Myocardial infarction—Etoposide—germ cell cancer	6.45e-05	0.00171	CcSEcCtD
Irinotecan—CYP2B6—skin of body—germ cell cancer	6.43e-05	0.00408	CbGeAlD
Irinotecan—ALB—testis—germ cell cancer	6.43e-05	0.00408	CbGeAlD
Irinotecan—SLC22A3—testis—germ cell cancer	6.42e-05	0.00407	CbGeAlD
Irinotecan—ABCC1—adrenal gland—germ cell cancer	6.42e-05	0.00407	CbGeAlD
Irinotecan—Jaundice—Etoposide—germ cell cancer	6.42e-05	0.0017	CcSEcCtD
Irinotecan—Stomatitis—Etoposide—germ cell cancer	6.42e-05	0.0017	CcSEcCtD
Irinotecan—Discomfort—Bleomycin—germ cell cancer	6.41e-05	0.00169	CcSEcCtD
Irinotecan—Malaise—Dactinomycin—germ cell cancer	6.41e-05	0.00169	CcSEcCtD
Irinotecan—Decreased appetite—Vinblastine—germ cell cancer	6.4e-05	0.00169	CcSEcCtD
Irinotecan—Neoplasm—Methotrexate—germ cell cancer	6.37e-05	0.00168	CcSEcCtD
Irinotecan—Leukopenia—Dactinomycin—germ cell cancer	6.36e-05	0.00168	CcSEcCtD
Irinotecan—ACHE—Peptide hormone metabolism—INHA—germ cell cancer	6.36e-05	0.0165	CbGpPWpGaD
Irinotecan—Connective tissue disorder—Cisplatin—germ cell cancer	6.34e-05	0.00168	CcSEcCtD
Irinotecan—ABCC2—endocrine gland—germ cell cancer	6.32e-05	0.00401	CbGeAlD
Irinotecan—Pain—Vinblastine—germ cell cancer	6.3e-05	0.00166	CcSEcCtD
Irinotecan—Constipation—Vinblastine—germ cell cancer	6.3e-05	0.00166	CcSEcCtD
Irinotecan—Confusional state—Bleomycin—germ cell cancer	6.27e-05	0.00166	CcSEcCtD
Irinotecan—BCHE—uterus—germ cell cancer	6.27e-05	0.00397	CbGeAlD
Irinotecan—Anaphylactic shock—Bleomycin—germ cell cancer	6.22e-05	0.00164	CcSEcCtD
Irinotecan—Oedema—Bleomycin—germ cell cancer	6.22e-05	0.00164	CcSEcCtD
Irinotecan—CYP2B6—Metapathway biotransformation—NAT9—germ cell cancer	6.22e-05	0.0161	CbGpPWpGaD
Irinotecan—Visual impairment—Cisplatin—germ cell cancer	6.22e-05	0.00164	CcSEcCtD
Irinotecan—Infection—Bleomycin—germ cell cancer	6.18e-05	0.00163	CcSEcCtD
Irinotecan—BCHE—pituitary gland—germ cell cancer	6.16e-05	0.0039	CbGeAlD
Irinotecan—Sepsis—Methotrexate—germ cell cancer	6.12e-05	0.00162	CcSEcCtD
Irinotecan—Thrombocytopenia—Bleomycin—germ cell cancer	6.09e-05	0.00161	CcSEcCtD
Irinotecan—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	6.08e-05	0.0157	CbGpPWpGaD
Irinotecan—Feeling abnormal—Vinblastine—germ cell cancer	6.07e-05	0.0016	CcSEcCtD
Irinotecan—ABCG2—uterus—germ cell cancer	6.06e-05	0.00384	CbGeAlD
Irinotecan—Ill-defined disorder—Ifosfamide—germ cell cancer	6.04e-05	0.0016	CcSEcCtD
Irinotecan—ABCC2—testis—germ cell cancer	6.03e-05	0.00382	CbGeAlD
Irinotecan—Gastrointestinal pain—Vinblastine—germ cell cancer	6.02e-05	0.00159	CcSEcCtD
Irinotecan—Anaemia—Ifosfamide—germ cell cancer	6.02e-05	0.00159	CcSEcCtD
Irinotecan—ALB—Transport of organic anions—AVP—germ cell cancer	6e-05	0.0155	CbGpPWpGaD
Irinotecan—Cardiac disorder—Cisplatin—germ cell cancer	5.99e-05	0.00158	CcSEcCtD
Irinotecan—Flushing—Cisplatin—germ cell cancer	5.99e-05	0.00158	CcSEcCtD
Irinotecan—ABCC1—female gonad—germ cell cancer	5.99e-05	0.00379	CbGeAlD
Irinotecan—Discomfort—Dactinomycin—germ cell cancer	5.98e-05	0.00158	CcSEcCtD
Irinotecan—ABCG2—pituitary gland—germ cell cancer	5.95e-05	0.00377	CbGeAlD
Irinotecan—BCHE—medulla oblongata—germ cell cancer	5.94e-05	0.00377	CbGeAlD
Irinotecan—Anorexia—Bleomycin—germ cell cancer	5.93e-05	0.00157	CcSEcCtD
Irinotecan—Thrombophlebitis—Methotrexate—germ cell cancer	5.91e-05	0.00156	CcSEcCtD
Irinotecan—Malaise—Ifosfamide—germ cell cancer	5.88e-05	0.00155	CcSEcCtD
Irinotecan—Vertigo—Ifosfamide—germ cell cancer	5.85e-05	0.00155	CcSEcCtD
Irinotecan—Leukopenia—Ifosfamide—germ cell cancer	5.83e-05	0.00154	CcSEcCtD
Irinotecan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	5.83e-05	0.0151	CbGpPWpGaD
Irinotecan—Immune system disorder—Cisplatin—germ cell cancer	5.83e-05	0.00154	CcSEcCtD
Irinotecan—Abdominal pain—Vinblastine—germ cell cancer	5.82e-05	0.00154	CcSEcCtD
Irinotecan—Mediastinal disorder—Cisplatin—germ cell cancer	5.81e-05	0.00154	CcSEcCtD
Irinotecan—Hypotension—Bleomycin—germ cell cancer	5.81e-05	0.00154	CcSEcCtD
Irinotecan—Oedema—Dactinomycin—germ cell cancer	5.8e-05	0.00153	CcSEcCtD
Irinotecan—Infection—Dactinomycin—germ cell cancer	5.76e-05	0.00152	CcSEcCtD
Irinotecan—Arrhythmia—Cisplatin—germ cell cancer	5.76e-05	0.00152	CcSEcCtD
Irinotecan—ABCG2—medulla oblongata—germ cell cancer	5.74e-05	0.00364	CbGeAlD
Irinotecan—Alopecia—Cisplatin—germ cell cancer	5.7e-05	0.00151	CcSEcCtD
Irinotecan—Cough—Ifosfamide—germ cell cancer	5.68e-05	0.0015	CcSEcCtD
Irinotecan—Thrombocytopenia—Dactinomycin—germ cell cancer	5.68e-05	0.0015	CcSEcCtD
Irinotecan—BCHE—Peptide hormone metabolism—INHA—germ cell cancer	5.67e-05	0.0147	CbGpPWpGaD
Irinotecan—ACHE—Peptide hormone metabolism—KLF4—germ cell cancer	5.67e-05	0.0147	CbGpPWpGaD
Irinotecan—CYP2B6—gonad—germ cell cancer	5.63e-05	0.00357	CbGeAlD
Irinotecan—Hypertension—Ifosfamide—germ cell cancer	5.62e-05	0.00149	CcSEcCtD
Irinotecan—Paraesthesia—Bleomycin—germ cell cancer	5.59e-05	0.00148	CcSEcCtD
Irinotecan—Dyspnoea—Bleomycin—germ cell cancer	5.55e-05	0.00147	CcSEcCtD
Irinotecan—Renal failure acute—Methotrexate—germ cell cancer	5.54e-05	0.00146	CcSEcCtD
Irinotecan—Flatulence—Cisplatin—germ cell cancer	5.53e-05	0.00146	CcSEcCtD
Irinotecan—Anorexia—Dactinomycin—germ cell cancer	5.53e-05	0.00146	CcSEcCtD
Irinotecan—BCHE—adrenal gland—germ cell cancer	5.5e-05	0.00349	CbGeAlD
Irinotecan—Flushing—Etoposide—germ cell cancer	5.49e-05	0.00145	CcSEcCtD
Irinotecan—Cardiac disorder—Etoposide—germ cell cancer	5.49e-05	0.00145	CcSEcCtD
Irinotecan—Discomfort—Ifosfamide—germ cell cancer	5.48e-05	0.00145	CcSEcCtD
Irinotecan—CES2—Fluoropyrimidine Activity—TP53—germ cell cancer	5.46e-05	0.0141	CbGpPWpGaD
Irinotecan—BCHE—midbrain—germ cell cancer	5.43e-05	0.00344	CbGeAlD
Irinotecan—Hypersensitivity—Vinblastine—germ cell cancer	5.43e-05	0.00143	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Methotrexate—germ cell cancer	5.42e-05	0.00143	CcSEcCtD
Irinotecan—Decreased appetite—Bleomycin—germ cell cancer	5.41e-05	0.00143	CcSEcCtD
Irinotecan—Visual disturbance—Methotrexate—germ cell cancer	5.4e-05	0.00143	CcSEcCtD
Irinotecan—Muscle spasms—Cisplatin—germ cell cancer	5.4e-05	0.00143	CcSEcCtD
Irinotecan—Angiopathy—Etoposide—germ cell cancer	5.36e-05	0.00142	CcSEcCtD
Irinotecan—Confusional state—Ifosfamide—germ cell cancer	5.36e-05	0.00142	CcSEcCtD
Irinotecan—Immune system disorder—Etoposide—germ cell cancer	5.34e-05	0.00141	CcSEcCtD
Irinotecan—Mediastinal disorder—Etoposide—germ cell cancer	5.33e-05	0.00141	CcSEcCtD
Irinotecan—Pain—Bleomycin—germ cell cancer	5.32e-05	0.00141	CcSEcCtD
Irinotecan—BCHE—bone marrow—germ cell cancer	5.32e-05	0.00337	CbGeAlD
Irinotecan—Oedema—Ifosfamide—germ cell cancer	5.32e-05	0.0014	CcSEcCtD
Irinotecan—Anaphylactic shock—Ifosfamide—germ cell cancer	5.32e-05	0.0014	CcSEcCtD
Irinotecan—ABCG2—adrenal gland—germ cell cancer	5.31e-05	0.00337	CbGeAlD
Irinotecan—ABCC1—testis—germ cell cancer	5.31e-05	0.00337	CbGeAlD
Irinotecan—Chills—Etoposide—germ cell cancer	5.3e-05	0.0014	CcSEcCtD
Irinotecan—BCHE—spinal cord—germ cell cancer	5.3e-05	0.00336	CbGeAlD
Irinotecan—Anaphylactoid reaction—Methotrexate—germ cell cancer	5.29e-05	0.0014	CcSEcCtD
Irinotecan—Asthenia—Vinblastine—germ cell cancer	5.29e-05	0.0014	CcSEcCtD
Irinotecan—Infection—Ifosfamide—germ cell cancer	5.28e-05	0.0014	CcSEcCtD
Irinotecan—ABCG2—midbrain—germ cell cancer	5.25e-05	0.00333	CbGeAlD
Irinotecan—Alopecia—Etoposide—germ cell cancer	5.22e-05	0.00138	CcSEcCtD
Irinotecan—Cerebrovascular accident—Methotrexate—germ cell cancer	5.22e-05	0.00138	CcSEcCtD
Irinotecan—Nervous system disorder—Ifosfamide—germ cell cancer	5.21e-05	0.00138	CcSEcCtD
Irinotecan—Ill-defined disorder—Cisplatin—germ cell cancer	5.21e-05	0.00138	CcSEcCtD
Irinotecan—Thrombocytopenia—Ifosfamide—germ cell cancer	5.21e-05	0.00138	CcSEcCtD
Irinotecan—Anaemia—Cisplatin—germ cell cancer	5.19e-05	0.00137	CcSEcCtD
Irinotecan—ABCG2—bone marrow—germ cell cancer	5.14e-05	0.00326	CbGeAlD
Irinotecan—Hyperhidrosis—Ifosfamide—germ cell cancer	5.14e-05	0.00136	CcSEcCtD
Irinotecan—Feeling abnormal—Bleomycin—germ cell cancer	5.13e-05	0.00135	CcSEcCtD
Irinotecan—ABCG2—spinal cord—germ cell cancer	5.12e-05	0.00324	CbGeAlD
Irinotecan—Osteoarthritis—Methotrexate—germ cell cancer	5.12e-05	0.00135	CcSEcCtD
Irinotecan—Anorexia—Ifosfamide—germ cell cancer	5.07e-05	0.00134	CcSEcCtD
Irinotecan—Malaise—Cisplatin—germ cell cancer	5.06e-05	0.00134	CcSEcCtD
Irinotecan—BCHE—Peptide hormone metabolism—KLF4—germ cell cancer	5.05e-05	0.0131	CbGpPWpGaD
Irinotecan—Decreased appetite—Dactinomycin—germ cell cancer	5.04e-05	0.00133	CcSEcCtD
Irinotecan—Diarrhoea—Vinblastine—germ cell cancer	5.04e-05	0.00133	CcSEcCtD
Irinotecan—Leukopenia—Cisplatin—germ cell cancer	5.03e-05	0.00133	CcSEcCtD
Irinotecan—Fatigue—Dactinomycin—germ cell cancer	5e-05	0.00132	CcSEcCtD
Irinotecan—TOP1—Circadian rythm related genes—AVP—germ cell cancer	5e-05	0.013	CbGpPWpGaD
Irinotecan—Back pain—Etoposide—germ cell cancer	4.98e-05	0.00132	CcSEcCtD
Irinotecan—Hypotension—Ifosfamide—germ cell cancer	4.97e-05	0.00131	CcSEcCtD
Irinotecan—Pain—Dactinomycin—germ cell cancer	4.96e-05	0.00131	CcSEcCtD
Irinotecan—ABCG2—female gonad—germ cell cancer	4.96e-05	0.00314	CbGeAlD
Irinotecan—Muscle spasms—Etoposide—germ cell cancer	4.95e-05	0.00131	CcSEcCtD
Irinotecan—Body temperature increased—Bleomycin—germ cell cancer	4.92e-05	0.0013	CcSEcCtD
Irinotecan—ABCC1—cerebellum—germ cell cancer	4.9e-05	0.00311	CbGeAlD
Irinotecan—CYP2B6—adrenal gland—germ cell cancer	4.9e-05	0.00311	CbGeAlD
Irinotecan—Dizziness—Vinblastine—germ cell cancer	4.87e-05	0.00129	CcSEcCtD
Irinotecan—ALB—brain—germ cell cancer	4.82e-05	0.00306	CbGeAlD
Irinotecan—SLC22A3—brain—germ cell cancer	4.82e-05	0.00305	CbGeAlD
Irinotecan—Feeling abnormal—Dactinomycin—germ cell cancer	4.78e-05	0.00126	CcSEcCtD
Irinotecan—Paraesthesia—Ifosfamide—germ cell cancer	4.77e-05	0.00126	CcSEcCtD
Irinotecan—Ill-defined disorder—Etoposide—germ cell cancer	4.77e-05	0.00126	CcSEcCtD
Irinotecan—BCHE—endocrine gland—germ cell cancer	4.77e-05	0.00302	CbGeAlD
Irinotecan—Anaemia—Etoposide—germ cell cancer	4.76e-05	0.00126	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dactinomycin—germ cell cancer	4.74e-05	0.00125	CcSEcCtD
Irinotecan—Dyspnoea—Ifosfamide—germ cell cancer	4.74e-05	0.00125	CcSEcCtD
Irinotecan—Somnolence—Ifosfamide—germ cell cancer	4.73e-05	0.00125	CcSEcCtD
Irinotecan—Discomfort—Cisplatin—germ cell cancer	4.72e-05	0.00125	CcSEcCtD
Irinotecan—BCHE—head—germ cell cancer	4.71e-05	0.00298	CbGeAlD
Irinotecan—Vomiting—Vinblastine—germ cell cancer	4.68e-05	0.00124	CcSEcCtD
Irinotecan—ALB—lymph node—germ cell cancer	4.66e-05	0.00296	CbGeAlD
Irinotecan—SLC22A3—lymph node—germ cell cancer	4.65e-05	0.00295	CbGeAlD
Irinotecan—Malaise—Etoposide—germ cell cancer	4.64e-05	0.00123	CcSEcCtD
Irinotecan—Vertigo—Etoposide—germ cell cancer	4.62e-05	0.00122	CcSEcCtD
Irinotecan—Decreased appetite—Ifosfamide—germ cell cancer	4.62e-05	0.00122	CcSEcCtD
Irinotecan—Headache—Vinblastine—germ cell cancer	4.61e-05	0.00122	CcSEcCtD
Irinotecan—Leukopenia—Etoposide—germ cell cancer	4.61e-05	0.00122	CcSEcCtD
Irinotecan—CYP3A5—female gonad—germ cell cancer	4.6e-05	0.00292	CbGeAlD
Irinotecan—Gastrointestinal disorder—Ifosfamide—germ cell cancer	4.59e-05	0.00121	CcSEcCtD
Irinotecan—ABCB1—trigeminal ganglion—germ cell cancer	4.59e-05	0.00291	CbGeAlD
Irinotecan—Body temperature increased—Dactinomycin—germ cell cancer	4.59e-05	0.00121	CcSEcCtD
Irinotecan—Abdominal pain—Dactinomycin—germ cell cancer	4.59e-05	0.00121	CcSEcCtD
Irinotecan—Fatigue—Ifosfamide—germ cell cancer	4.58e-05	0.00121	CcSEcCtD
Irinotecan—Anaphylactic shock—Cisplatin—germ cell cancer	4.58e-05	0.00121	CcSEcCtD
Irinotecan—Oedema—Cisplatin—germ cell cancer	4.58e-05	0.00121	CcSEcCtD
Irinotecan—Hypersensitivity—Bleomycin—germ cell cancer	4.58e-05	0.00121	CcSEcCtD
Irinotecan—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	4.58e-05	0.0119	CbGpPWpGaD
Irinotecan—Infection—Cisplatin—germ cell cancer	4.55e-05	0.0012	CcSEcCtD
Irinotecan—BCHE—testis—germ cell cancer	4.55e-05	0.00288	CbGeAlD
Irinotecan—Constipation—Ifosfamide—germ cell cancer	4.55e-05	0.0012	CcSEcCtD
Irinotecan—Pain—Ifosfamide—germ cell cancer	4.55e-05	0.0012	CcSEcCtD
Irinotecan—Loss of consciousness—Etoposide—germ cell cancer	4.52e-05	0.0012	CcSEcCtD
Irinotecan—Nervous system disorder—Cisplatin—germ cell cancer	4.5e-05	0.00119	CcSEcCtD
Irinotecan—Cough—Etoposide—germ cell cancer	4.49e-05	0.00119	CcSEcCtD
Irinotecan—Thrombocytopenia—Cisplatin—germ cell cancer	4.49e-05	0.00119	CcSEcCtD
Irinotecan—Asthenia—Bleomycin—germ cell cancer	4.46e-05	0.00118	CcSEcCtD
Irinotecan—Hypertension—Etoposide—germ cell cancer	4.44e-05	0.00117	CcSEcCtD
Irinotecan—Hyperhidrosis—Cisplatin—germ cell cancer	4.43e-05	0.00117	CcSEcCtD
Irinotecan—ABCB1—embryo—germ cell cancer	4.43e-05	0.00281	CbGeAlD
Irinotecan—ABCG2—testis—germ cell cancer	4.39e-05	0.00279	CbGeAlD
Irinotecan—Feeling abnormal—Ifosfamide—germ cell cancer	4.38e-05	0.00116	CcSEcCtD
Irinotecan—Nausea—Vinblastine—germ cell cancer	4.38e-05	0.00116	CcSEcCtD
Irinotecan—Anorexia—Cisplatin—germ cell cancer	4.37e-05	0.00115	CcSEcCtD
Irinotecan—ABCC2—lymph node—germ cell cancer	4.37e-05	0.00277	CbGeAlD
Irinotecan—Gastrointestinal pain—Ifosfamide—germ cell cancer	4.35e-05	0.00115	CcSEcCtD
Irinotecan—Pancreatitis—Methotrexate—germ cell cancer	4.34e-05	0.00115	CcSEcCtD
Irinotecan—Discomfort—Etoposide—germ cell cancer	4.33e-05	0.00114	CcSEcCtD
Irinotecan—Hypotension—Cisplatin—germ cell cancer	4.28e-05	0.00113	CcSEcCtD
Irinotecan—CYP3A5—endocrine gland—germ cell cancer	4.28e-05	0.00271	CbGeAlD
Irinotecan—Hypersensitivity—Dactinomycin—germ cell cancer	4.27e-05	0.00113	CcSEcCtD
Irinotecan—CYP2B6—endocrine gland—germ cell cancer	4.25e-05	0.00269	CbGeAlD
Irinotecan—Confusional state—Etoposide—germ cell cancer	4.23e-05	0.00112	CcSEcCtD
Irinotecan—Abdominal pain—Ifosfamide—germ cell cancer	4.2e-05	0.00111	CcSEcCtD
Irinotecan—Body temperature increased—Ifosfamide—germ cell cancer	4.2e-05	0.00111	CcSEcCtD
Irinotecan—BCHE—cerebellum—germ cell cancer	4.2e-05	0.00266	CbGeAlD
Irinotecan—Anaphylactic shock—Etoposide—germ cell cancer	4.2e-05	0.00111	CcSEcCtD
Irinotecan—CYP2B6—head—germ cell cancer	4.2e-05	0.00266	CbGeAlD
Irinotecan—Infection—Etoposide—germ cell cancer	4.17e-05	0.0011	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—germ cell cancer	4.16e-05	0.0011	CcSEcCtD
Irinotecan—Neutropenia—Methotrexate—germ cell cancer	4.14e-05	0.00109	CcSEcCtD
Irinotecan—Paraesthesia—Cisplatin—germ cell cancer	4.12e-05	0.00109	CcSEcCtD
Irinotecan—Thrombocytopenia—Etoposide—germ cell cancer	4.11e-05	0.00109	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Methotrexate—germ cell cancer	4.11e-05	0.00109	CcSEcCtD
Irinotecan—Dyspnoea—Cisplatin—germ cell cancer	4.09e-05	0.00108	CcSEcCtD
Irinotecan—Hyperhidrosis—Etoposide—germ cell cancer	4.06e-05	0.00107	CcSEcCtD
Irinotecan—ABCG2—cerebellum—germ cell cancer	4.06e-05	0.00257	CbGeAlD
Irinotecan—CYP2B6—testis—germ cell cancer	4.05e-05	0.00257	CbGeAlD
Irinotecan—Anorexia—Etoposide—germ cell cancer	4e-05	0.00106	CcSEcCtD
Irinotecan—Decreased appetite—Cisplatin—germ cell cancer	3.98e-05	0.00105	CcSEcCtD
Irinotecan—ABCC1—brain—germ cell cancer	3.98e-05	0.00252	CbGeAlD
Irinotecan—Diarrhoea—Dactinomycin—germ cell cancer	3.97e-05	0.00105	CcSEcCtD
Irinotecan—Pneumonia—Methotrexate—germ cell cancer	3.97e-05	0.00105	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Cisplatin—germ cell cancer	3.96e-05	0.00105	CcSEcCtD
Irinotecan—Vomiting—Bleomycin—germ cell cancer	3.96e-05	0.00105	CcSEcCtD
Irinotecan—Hypotension—Etoposide—germ cell cancer	3.92e-05	0.00104	CcSEcCtD
Irinotecan—Rash—Bleomycin—germ cell cancer	3.92e-05	0.00104	CcSEcCtD
Irinotecan—Pain—Cisplatin—germ cell cancer	3.92e-05	0.00104	CcSEcCtD
Irinotecan—Dermatitis—Bleomycin—germ cell cancer	3.92e-05	0.00104	CcSEcCtD
Irinotecan—Hypersensitivity—Ifosfamide—germ cell cancer	3.92e-05	0.00104	CcSEcCtD
Irinotecan—ABCB1—retina—germ cell cancer	3.92e-05	0.00248	CbGeAlD
Irinotecan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	3.9e-05	0.0101	CbGpPWpGaD
Irinotecan—Renal failure—Methotrexate—germ cell cancer	3.88e-05	0.00102	CcSEcCtD
Irinotecan—ABCC1—lymph node—germ cell cancer	3.85e-05	0.00244	CbGeAlD
Irinotecan—Stomatitis—Methotrexate—germ cell cancer	3.84e-05	0.00102	CcSEcCtD
Irinotecan—Asthenia—Ifosfamide—germ cell cancer	3.81e-05	0.00101	CcSEcCtD
Irinotecan—Sweating—Methotrexate—germ cell cancer	3.78e-05	0.000999	CcSEcCtD
Irinotecan—Feeling abnormal—Cisplatin—germ cell cancer	3.78e-05	0.000998	CcSEcCtD
Irinotecan—Paraesthesia—Etoposide—germ cell cancer	3.77e-05	0.000996	CcSEcCtD
Irinotecan—Dyspnoea—Etoposide—germ cell cancer	3.74e-05	0.000989	CcSEcCtD
Irinotecan—Somnolence—Etoposide—germ cell cancer	3.73e-05	0.000986	CcSEcCtD
Irinotecan—Nausea—Bleomycin—germ cell cancer	3.7e-05	0.000976	CcSEcCtD
Irinotecan—Vomiting—Dactinomycin—germ cell cancer	3.69e-05	0.000975	CcSEcCtD
Irinotecan—Rash—Dactinomycin—germ cell cancer	3.66e-05	0.000967	CcSEcCtD
Irinotecan—Decreased appetite—Etoposide—germ cell cancer	3.65e-05	0.000965	CcSEcCtD
Irinotecan—Diarrhoea—Ifosfamide—germ cell cancer	3.64e-05	0.000961	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Etoposide—germ cell cancer	3.63e-05	0.000958	CcSEcCtD
Irinotecan—Body temperature increased—Cisplatin—germ cell cancer	3.62e-05	0.000958	CcSEcCtD
Irinotecan—Fatigue—Etoposide—germ cell cancer	3.62e-05	0.000957	CcSEcCtD
Irinotecan—ABCB1—telencephalon—germ cell cancer	3.6e-05	0.00228	CbGeAlD
Irinotecan—Pain—Etoposide—germ cell cancer	3.59e-05	0.000949	CcSEcCtD
Irinotecan—Constipation—Etoposide—germ cell cancer	3.59e-05	0.000949	CcSEcCtD
Irinotecan—Haemoglobin—Methotrexate—germ cell cancer	3.56e-05	0.00094	CcSEcCtD
Irinotecan—Haemorrhage—Methotrexate—germ cell cancer	3.54e-05	0.000936	CcSEcCtD
Irinotecan—CES2—E2F transcription factor network—MYC—germ cell cancer	3.52e-05	0.00912	CbGpPWpGaD
Irinotecan—Dizziness—Ifosfamide—germ cell cancer	3.52e-05	0.000929	CcSEcCtD
Irinotecan—Feeling abnormal—Etoposide—germ cell cancer	3.46e-05	0.000914	CcSEcCtD
Irinotecan—Nausea—Dactinomycin—germ cell cancer	3.45e-05	0.000911	CcSEcCtD
Irinotecan—Gastrointestinal pain—Etoposide—germ cell cancer	3.43e-05	0.000907	CcSEcCtD
Irinotecan—ABCB1—decidua—germ cell cancer	3.41e-05	0.00216	CbGeAlD
Irinotecan—Visual impairment—Methotrexate—germ cell cancer	3.41e-05	0.000902	CcSEcCtD
Irinotecan—BCHE—brain—germ cell cancer	3.41e-05	0.00216	CbGeAlD
Irinotecan—Vomiting—Ifosfamide—germ cell cancer	3.38e-05	0.000893	CcSEcCtD
Irinotecan—Hypersensitivity—Cisplatin—germ cell cancer	3.38e-05	0.000892	CcSEcCtD
Irinotecan—Rash—Ifosfamide—germ cell cancer	3.35e-05	0.000886	CcSEcCtD
Irinotecan—Dermatitis—Ifosfamide—germ cell cancer	3.35e-05	0.000885	CcSEcCtD
Irinotecan—Body temperature increased—Etoposide—germ cell cancer	3.32e-05	0.000877	CcSEcCtD
Irinotecan—Abdominal pain—Etoposide—germ cell cancer	3.32e-05	0.000877	CcSEcCtD
Irinotecan—ABCG2—brain—germ cell cancer	3.3e-05	0.00209	CbGeAlD
Irinotecan—BCHE—lymph node—germ cell cancer	3.3e-05	0.00209	CbGeAlD
Irinotecan—Asthenia—Cisplatin—germ cell cancer	3.29e-05	0.000869	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—germ cell cancer	3.29e-05	0.000868	CcSEcCtD
Irinotecan—CES1—Fluoropyrimidine Activity—TP53—germ cell cancer	3.22e-05	0.00833	CbGpPWpGaD
Irinotecan—Angiopathy—Methotrexate—germ cell cancer	3.21e-05	0.000849	CcSEcCtD
Irinotecan—CYP3A4—endocrine gland—germ cell cancer	3.21e-05	0.00203	CbGeAlD
Irinotecan—Immune system disorder—Methotrexate—germ cell cancer	3.2e-05	0.000845	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—germ cell cancer	3.19e-05	0.000843	CcSEcCtD
Irinotecan—ABCG2—lymph node—germ cell cancer	3.19e-05	0.00202	CbGeAlD
Irinotecan—Chills—Methotrexate—germ cell cancer	3.18e-05	0.000839	CcSEcCtD
Irinotecan—Nausea—Ifosfamide—germ cell cancer	3.16e-05	0.000835	CcSEcCtD
Irinotecan—UGT1A1—NRF2 pathway—SLC2A3—germ cell cancer	3.14e-05	0.00813	CbGpPWpGaD
Irinotecan—UGT1A9—NRF2 pathway—SLC2A3—germ cell cancer	3.14e-05	0.00813	CbGpPWpGaD
Irinotecan—Diarrhoea—Cisplatin—germ cell cancer	3.14e-05	0.000829	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—germ cell cancer	3.13e-05	0.000827	CcSEcCtD
Irinotecan—Hypersensitivity—Etoposide—germ cell cancer	3.09e-05	0.000818	CcSEcCtD
Irinotecan—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	3.06e-05	0.00793	CbGpPWpGaD
Irinotecan—CYP2B6—brain—germ cell cancer	3.04e-05	0.00193	CbGeAlD
Irinotecan—Asthenia—Etoposide—germ cell cancer	3.01e-05	0.000796	CcSEcCtD
Irinotecan—ABCB1—gonad—germ cell cancer	3.01e-05	0.00191	CbGeAlD
Irinotecan—ABCB1—uterus—germ cell cancer	2.99e-05	0.00189	CbGeAlD
Irinotecan—Back pain—Methotrexate—germ cell cancer	2.98e-05	0.000788	CcSEcCtD
Irinotecan—ABCB1—pituitary gland—germ cell cancer	2.93e-05	0.00186	CbGeAlD
Irinotecan—Vomiting—Cisplatin—germ cell cancer	2.91e-05	0.00077	CcSEcCtD
Irinotecan—Rash—Cisplatin—germ cell cancer	2.89e-05	0.000764	CcSEcCtD
Irinotecan—Dermatitis—Cisplatin—germ cell cancer	2.89e-05	0.000763	CcSEcCtD
Irinotecan—Diarrhoea—Etoposide—germ cell cancer	2.87e-05	0.000759	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—germ cell cancer	2.86e-05	0.000756	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—germ cell cancer	2.85e-05	0.000753	CcSEcCtD
Irinotecan—ABCB1—medulla oblongata—germ cell cancer	2.83e-05	0.00179	CbGeAlD
Irinotecan—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	2.83e-05	0.00732	CbGpPWpGaD
Irinotecan—Malaise—Methotrexate—germ cell cancer	2.78e-05	0.000734	CcSEcCtD
Irinotecan—Dizziness—Etoposide—germ cell cancer	2.78e-05	0.000734	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—germ cell cancer	2.77e-05	0.000732	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—germ cell cancer	2.76e-05	0.000729	CcSEcCtD
Irinotecan—Nausea—Cisplatin—germ cell cancer	2.72e-05	0.000719	CcSEcCtD
Irinotecan—Cough—Methotrexate—germ cell cancer	2.69e-05	0.000711	CcSEcCtD
Irinotecan—Vomiting—Etoposide—germ cell cancer	2.67e-05	0.000706	CcSEcCtD
Irinotecan—SLC22A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	2.65e-05	0.00686	CbGpPWpGaD
Irinotecan—Rash—Etoposide—germ cell cancer	2.65e-05	0.0007	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—germ cell cancer	2.65e-05	0.000699	CcSEcCtD
Irinotecan—Headache—Etoposide—germ cell cancer	2.63e-05	0.000695	CcSEcCtD
Irinotecan—ABCB1—adrenal gland—germ cell cancer	2.62e-05	0.00166	CbGeAlD
Irinotecan—Discomfort—Methotrexate—germ cell cancer	2.59e-05	0.000685	CcSEcCtD
Irinotecan—ABCB1—midbrain—germ cell cancer	2.59e-05	0.00164	CbGeAlD
Irinotecan—ALB—Platelet degranulation—CD9—germ cell cancer	2.58e-05	0.00669	CbGpPWpGaD
Irinotecan—Confusional state—Methotrexate—germ cell cancer	2.54e-05	0.00067	CcSEcCtD
Irinotecan—ABCB1—bone marrow—germ cell cancer	2.54e-05	0.00161	CbGeAlD
Irinotecan—ABCB1—spinal cord—germ cell cancer	2.52e-05	0.0016	CbGeAlD
Irinotecan—Anaphylactic shock—Methotrexate—germ cell cancer	2.52e-05	0.000665	CcSEcCtD
Irinotecan—Infection—Methotrexate—germ cell cancer	2.5e-05	0.00066	CcSEcCtD
Irinotecan—Nausea—Etoposide—germ cell cancer	2.49e-05	0.000659	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—germ cell cancer	2.47e-05	0.000652	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—germ cell cancer	2.46e-05	0.000651	CcSEcCtD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	2.46e-05	0.00637	CbGpPWpGaD
Irinotecan—ABCB1—female gonad—germ cell cancer	2.44e-05	0.00155	CbGeAlD
Irinotecan—Hyperhidrosis—Methotrexate—germ cell cancer	2.43e-05	0.000643	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—germ cell cancer	2.4e-05	0.000634	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—germ cell cancer	2.35e-05	0.000621	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—germ cell cancer	2.28e-05	0.000601	CcSEcCtD
Irinotecan—ABCB1—endocrine gland—germ cell cancer	2.27e-05	0.00144	CbGeAlD
Irinotecan—Paraesthesia—Methotrexate—germ cell cancer	2.26e-05	0.000597	CcSEcCtD
Irinotecan—ABCB1—head—germ cell cancer	2.24e-05	0.00142	CbGeAlD
Irinotecan—Dyspnoea—Methotrexate—germ cell cancer	2.24e-05	0.000593	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—germ cell cancer	2.24e-05	0.000591	CcSEcCtD
Irinotecan—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	2.23e-05	0.00576	CbGpPWpGaD
Irinotecan—Dyspepsia—Methotrexate—germ cell cancer	2.21e-05	0.000585	CcSEcCtD
Irinotecan—UGT1A9—PPAR Alpha Pathway—MYC—germ cell cancer	2.21e-05	0.00573	CbGpPWpGaD
Irinotecan—Decreased appetite—Methotrexate—germ cell cancer	2.19e-05	0.000578	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—germ cell cancer	2.17e-05	0.000574	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—germ cell cancer	2.17e-05	0.000573	CcSEcCtD
Irinotecan—ABCB1—testis—germ cell cancer	2.17e-05	0.00137	CbGeAlD
Irinotecan—Pain—Methotrexate—germ cell cancer	2.15e-05	0.000568	CcSEcCtD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	2.13e-05	0.00552	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—MYC—germ cell cancer	2.08e-05	0.00537	CbGpPWpGaD
Irinotecan—Feeling abnormal—Methotrexate—germ cell cancer	2.07e-05	0.000548	CcSEcCtD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.06e-05	0.00533	CbGpPWpGaD
Irinotecan—Gastrointestinal pain—Methotrexate—germ cell cancer	2.06e-05	0.000544	CcSEcCtD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	2.05e-05	0.00532	CbGpPWpGaD
Irinotecan—ABCB1—cerebellum—germ cell cancer	2e-05	0.00127	CbGeAlD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2e-05	0.00518	CbGpPWpGaD
Irinotecan—Body temperature increased—Methotrexate—germ cell cancer	1.99e-05	0.000525	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—germ cell cancer	1.99e-05	0.000525	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—germ cell cancer	1.85e-05	0.00049	CcSEcCtD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	1.81e-05	0.0047	CbGpPWpGaD
Irinotecan—Asthenia—Methotrexate—germ cell cancer	1.8e-05	0.000477	CcSEcCtD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	1.79e-05	0.00463	CbGpPWpGaD
Irinotecan—Diarrhoea—Methotrexate—germ cell cancer	1.72e-05	0.000455	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—germ cell cancer	1.66e-05	0.00044	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.64e-05	0.00426	CbGpPWpGaD
Irinotecan—ABCB1—brain—germ cell cancer	1.63e-05	0.00103	CbGeAlD
Irinotecan—Vomiting—Methotrexate—germ cell cancer	1.6e-05	0.000423	CcSEcCtD
Irinotecan—Rash—Methotrexate—germ cell cancer	1.59e-05	0.000419	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—germ cell cancer	1.58e-05	0.000419	CcSEcCtD
Irinotecan—TOP1—Circadian rythm related genes—TP53—germ cell cancer	1.58e-05	0.00409	CbGpPWpGaD
Irinotecan—Headache—Methotrexate—germ cell cancer	1.58e-05	0.000416	CcSEcCtD
Irinotecan—ABCB1—lymph node—germ cell cancer	1.57e-05	0.000996	CbGeAlD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.5e-05	0.00388	CbGpPWpGaD
Irinotecan—Nausea—Methotrexate—germ cell cancer	1.49e-05	0.000395	CcSEcCtD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.48e-05	0.00384	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.41e-05	0.00365	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.35e-05	0.00349	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.3e-05	0.00338	CbGpPWpGaD
Irinotecan—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	1.27e-05	0.0033	CbGpPWpGaD
Irinotecan—SLC22A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	1.22e-05	0.00316	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—INHA—germ cell cancer	1.2e-05	0.00311	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	1.15e-05	0.00297	CbGpPWpGaD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	1.13e-05	0.00293	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	1.11e-05	0.00288	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—INHA—germ cell cancer	1.07e-05	0.00277	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—KLF4—germ cell cancer	1.07e-05	0.00277	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	1.04e-05	0.00268	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	1.02e-05	0.00264	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.81e-06	0.00254	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.7e-06	0.00251	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.67e-06	0.0025	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.55e-06	0.00247	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—KLF4—germ cell cancer	9.54e-06	0.00247	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.22e-06	0.00239	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.08e-06	0.00235	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.95e-06	0.00232	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	8.53e-06	0.00221	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.49e-06	0.0022	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	8.41e-06	0.00218	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—AVP—germ cell cancer	8.36e-06	0.00217	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.19e-06	0.00212	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.05e-06	0.00208	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	7.98e-06	0.00207	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	7.78e-06	0.00202	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.05e-06	0.00183	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—SLC2A3—germ cell cancer	6.31e-06	0.00163	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—AVP—germ cell cancer	6.21e-06	0.00161	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	6.11e-06	0.00158	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—CD9—germ cell cancer	5.9e-06	0.00153	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SLC2A3—germ cell cancer	5.42e-06	0.0014	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.27e-06	0.00136	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.19e-06	0.00134	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CRABP1—germ cell cancer	5.06e-06	0.00131	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—SLC2A3—germ cell cancer	4.96e-06	0.00129	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—SLC22A3—germ cell cancer	4.89e-06	0.00127	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.78e-06	0.00124	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.73e-06	0.00122	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—SLC2A3—germ cell cancer	4.71e-06	0.00122	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—SLC2A3—germ cell cancer	4.71e-06	0.00122	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—SLC22A3—germ cell cancer	4.64e-06	0.0012	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—SLC22A3—germ cell cancer	4.64e-06	0.0012	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.61e-06	0.00119	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.54e-06	0.00118	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—SLC2A3—germ cell cancer	4.54e-06	0.00118	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	4.53e-06	0.00117	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—germ cell cancer	4.51e-06	0.00117	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—SLC22A3—germ cell cancer	4.47e-06	0.00116	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.47e-06	0.00116	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.45e-06	0.00115	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—SLC2A3—germ cell cancer	4.43e-06	0.00115	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—SLC22A3—germ cell cancer	4.36e-06	0.00113	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SLC2A3—germ cell cancer	4.32e-06	0.00112	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SLC22A3—germ cell cancer	4.25e-06	0.0011	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.25e-06	0.0011	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC2A3—germ cell cancer	4e-06	0.00103	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CRABP1—germ cell cancer	3.99e-06	0.00103	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC2A3—germ cell cancer	3.96e-06	0.00103	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC22A3—germ cell cancer	3.94e-06	0.00102	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.94e-06	0.00102	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC22A3—germ cell cancer	3.9e-06	0.00101	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.88e-06	0.00101	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CRABP1—germ cell cancer	3.78e-06	0.000979	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CRABP1—germ cell cancer	3.78e-06	0.000979	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CRABP1—germ cell cancer	3.65e-06	0.000944	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.58e-06	0.000927	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CRABP1—germ cell cancer	3.56e-06	0.000921	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CRABP1—germ cell cancer	3.47e-06	0.000898	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CRABP1—germ cell cancer	3.21e-06	0.000831	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.19e-06	0.000827	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CRABP1—germ cell cancer	3.18e-06	0.000824	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGF4—germ cell cancer	3.11e-06	0.000807	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC2A3—germ cell cancer	2.93e-06	0.000759	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC22A3—germ cell cancer	2.89e-06	0.000747	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC2A3—germ cell cancer	2.86e-06	0.000742	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC22A3—germ cell cancer	2.82e-06	0.00073	CbGpPWpGaD
Irinotecan—ABCC1—Disease—H2AFZ—germ cell cancer	2.78e-06	0.00072	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—germ cell cancer	2.74e-06	0.00071	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KITLG—germ cell cancer	2.56e-06	0.000663	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC2A3—germ cell cancer	2.47e-06	0.000639	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—germ cell cancer	2.45e-06	0.000634	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC22A3—germ cell cancer	2.43e-06	0.000629	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	2.43e-06	0.000629	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CRABP1—germ cell cancer	2.35e-06	0.000609	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CRABP1—germ cell cancer	2.3e-06	0.000595	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.16e-06	0.00056	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.13e-06	0.000551	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.13e-06	0.000551	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.06e-06	0.000533	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CRABP1—germ cell cancer	1.98e-06	0.000513	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGFR3—germ cell cancer	1.9e-06	0.000493	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KIT—germ cell cancer	1.75e-06	0.000452	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CRABP1—germ cell cancer	1.74e-06	0.000449	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.69e-06	0.000438	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.33e-06	0.000345	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.31e-06	0.00034	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.07e-06	0.000277	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—germ cell cancer	9.61e-07	0.000249	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—germ cell cancer	8.85e-07	0.000229	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—germ cell cancer	8.46e-07	0.000219	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—germ cell cancer	7.55e-07	0.000195	CbGpPWpGaD
